Nutriband Inc.
NTRBNASDAQHealthcare● Active
$3.45
$-0.08(-2.27%)
Market Cap$41938200
P/E Ratio—
52W High$11.678
52W Low$3.209
Nutriband Inc. (NTRB) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NTRB · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 29, 2026EPS Actual
-$0.04
Est. -$1.89 · +97.9%
Revenue
$0.00B
Est. $0.00B · +0.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 29, 2026
After Market Close
▲ Beat EPS✓ 2-Quarter EPS Beat Streak
NTRB reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Jun 5, 2026 | — | — | — | — | — | — |
| ▲ Q2 FY2026 | Apr 29, 2026 | -$1.89 | -$0.04 | +97.9% | $0.00B | $0.00B | +0.0% |
| ▲ Q4 FY2025 | Dec 16, 2025 | -$2.13 | -$0.12 | +94.4% | $0.00B | $0.00B | -48.7% |
| ▼ Q3 FY2025 | Sep 9, 2025 | -$0.17 | -$2.12 | -1147.1% | $0.00B | $0.00B | -7.8% |
| ▲ Q2 FY2025 | May 30, 2025 | -$0.13 | -$0.12 | +7.7% | $0.00B | $0.00B | -5.3% |
| ▼ Q2 FY2025 | Apr 28, 2025 | -$0.12 | -$0.18 | -50.0% | $0.00B | $0.00B | -9.5% |
| — Q4 FY2024 | Dec 3, 2024 | — | -$0.12 | — | $0.00B | — | — |
| — Q3 FY2024 | Sep 3, 2024 | — | -$0.12 | — | $0.00B | — | — |
Q2 FY2026
Jun 5, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 29, 2026Beat
EPS Actual
-$0.04
EPS Est.
-$1.89
EPS Surpr.
+97.9%
Revenue
$0.00B
Q4 FY2025
Dec 16, 2025Beat
EPS Actual
-$0.12
EPS Est.
-$2.13
EPS Surpr.
+94.4%
Revenue
$0.00B
Q3 FY2025
Sep 9, 2025Miss
EPS Actual
-$2.12
EPS Est.
-$0.17
EPS Surpr.
-1147.1%
Revenue
$0.00B
Q2 FY2025
May 30, 2025Beat
EPS Actual
-$0.12
EPS Est.
-$0.13
EPS Surpr.
+7.7%
Revenue
$0.00B
Q2 FY2025
Apr 28, 2025Miss
EPS Actual
-$0.18
EPS Est.
-$0.12
EPS Surpr.
-50.0%
Revenue
$0.00B
Q4 FY2024
Dec 3, 2024
EPS Actual
-$0.12
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2024
Sep 3, 2024
EPS Actual
-$0.12
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2026 | $-1.89 | $-1.89 | $-1.89 | 1 |
| Q4 FY2025 | $-2.13 | $-2.13 | $-2.13 | 1 |
| Q3 FY2025 | $-2.12 | $-2.12 | $-2.12 | 1 |
| Q2 FY2025 | $-0.12 | $-0.12 | $-0.12 | 1 |
| Q1 FY2025 | $-0.50 | $-0.50 | $-0.50 | 1 |
| Q3 FY2024 | $-0.05 | $-0.05 | $-0.05 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 29, 2026 | +97.9% | $3.76 | $3.79 | +0.80% |
| ▲ Q4 FY2025 | Dec 16, 2025 | +94.4% | $4.84 | $4.49 | -7.23% |
| ▼ Q3 FY2025 | Sep 9, 2025 | -1147.1% | $6.26 | $6.08 | -2.88% |
| ▲ Q2 FY2025 | May 30, 2025 | +7.7% | $6.46 | $6.50 | +0.62% |
| ▼ Q2 FY2025 | Apr 28, 2025 | -50.0% | $5.32 | $5.84 | +9.77% |
| — Q4 FY2024 | Dec 3, 2024 | — | $4.55 | $4.14 | -9.01% |
| — Q3 FY2024 | Sep 3, 2024 | — | $4.08 | $4.71 | +15.44% |
| — Q2 FY2024 | May 31, 2024 | — | $5.05 | $5.45 | +7.92% |
Q2 FY2026+0.80%
Report Date
Apr 29, 2026
EPS Beat/Miss
+97.9%
Price Before
$3.76
Price After
$3.79
Q4 FY2025-7.23%
Report Date
Dec 16, 2025
EPS Beat/Miss
+94.4%
Price Before
$4.84
Price After
$4.49
Q3 FY2025-2.88%
Report Date
Sep 9, 2025
EPS Beat/Miss
-1147.1%
Price Before
$6.26
Price After
$6.08
Q2 FY2025+0.62%
Report Date
May 30, 2025
EPS Beat/Miss
+7.7%
Price Before
$6.46
Price After
$6.50
Q2 FY2025+9.77%
Report Date
Apr 28, 2025
EPS Beat/Miss
-50.0%
Price Before
$5.32
Price After
$5.84
Q4 FY2024-9.01%
Report Date
Dec 3, 2024
EPS Beat/Miss
—
Price Before
$4.55
Price After
$4.14
Q3 FY2024+15.44%
Report Date
Sep 3, 2024
EPS Beat/Miss
—
Price Before
$4.08
Price After
$4.71
Q2 FY2024+7.92%
Report Date
May 31, 2024
EPS Beat/Miss
—
Price Before
$5.05
Price After
$5.45
Avg Beat Reaction-1.94%
Avg Miss Reaction+3.44%
Beat Rate3 / 8 quarters
Largest Move+15.44% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NTRB ends December
Nutriband Inc. (NTRB) most recently reported earnings on April 29, 2026 for Q2 FY2026, posting EPS of $-0.04 — beating the analyst consensus of $-1.89 by +97.9%. NTRB has beaten EPS estimates for 2 consecutive quarters. The next NTRB earnings date is expected around September 1, 2026.
Each quarter, investors track NTRB earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NTRB revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NTRB's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NTRB earnings · 5 questionsNutriband Inc.'s next earnings report is expected around September 1, 2026. NTRB typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NTRB historically reports after market close (AMC).
NTRB earnings datewhen is NTRB earningsNTRB next earnings datewhen does NTRB report earningsNTRB earnings calendar
▸ Source: FMP · Nutriband Inc. SEC filings · US GAAP · Nutriband Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026